Tumor Heterogeneity and Growth Control
暂无分享,去创建一个
[1] J. Leith,et al. Tumor radiocurability: relationship to intrinsic tumor heterogeneity and to the tumor bed effect. , 1990, Invasion & metastasis.
[2] Roger S. Day,et al. A branching-process model for heterogeneous cell populations , 1986 .
[3] J A Adam,et al. Diffusion regulated growth characteristics of a spherical prevascular carcinoma. , 1990, Bulletin of mathematical biology.
[4] S. Michelson. Comparison of Stochastic Models for Tumor Escape , 1986 .
[5] J. Leith,et al. Growth properties of artificial heterogeneous human colon tumors. , 1987, Cancer research.
[6] T Kuczek,et al. Mathematical modeling for tumor resistance. , 1988, Journal of the National Cancer Institute.
[7] L. Révész,et al. Analysis of the growth of tumor cell populations , 1974 .
[8] B. Fisher,et al. Experimental studies of factors influencing hepatic metastases. I. The effect of number of tumor cells injected and time of growth , 1959, Cancer.
[9] Elliott W. Montroll,et al. Nonlinear Population Dynamics. (Book Reviews: On the Volterra and Other Nonlinear Models of Interacting Populations) , 1971 .
[10] A theoretical explanation of "concomitant resistance". , 1995, Bulletin of mathematical biology.
[11] J. Rubin,et al. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Leith,et al. Growth factors and growth control of heterogeneous cell populations. , 1993, Bulletin of mathematical biology.
[13] J. Leith,et al. Tumor micro-ecology and competitive interactions. , 1987, Journal of theoretical biology.
[14] M. Brattain,et al. Heterogeneity of malignant cells from a human colonic carcinoma. , 1981, Cancer research.
[15] J. Leith,et al. Tumor bed expression in xenografted artificial heterogeneous colon tumors. , 1988, International journal of radiation oncology, biology, physics.
[16] I. Fidler,et al. Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Taub,et al. The gene encoding rat insulinlike growth factor-binding protein 1 is rapidly and highly induced in regenerating liver , 1991, Molecular and cellular biology.
[18] A SIMPLE MODEL OF A STEADY STATE DIFFERENTIATING CELL SYSTEM , 1969, The Journal of cell biology.
[19] B. Stoll. Spontaneous regression of cancer: New insights , 1992, Biotherapy.
[20] J. Leith,et al. Modification of the growth rates and hypoxic fractions of xenografted A431 tumors by sialoadenectomy or exogenously supplied epidermal growth factor. , 1991, Cancer research.
[21] G. F. Webb,et al. A NONLINEAR CELL POPULATION MODEL OF PERIODIC CHEMOTHERAPY TREATMENT , 1992 .
[22] James H. Goldie,et al. The effect of cellular differentiation on the development of permanent drug resistance , 1985 .
[23] K. Ito,et al. Stochastic models for subpopulation emergence in heterogeneous tumors , 1989 .
[24] A. Cantarow,et al. Tumor growth in partially hepatectomized rats. , 1955, Cancer research.
[25] M. Sporn,et al. Type beta transforming growth factor: a bifunctional regulator of cellular growth. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[26] F. Miller,et al. Tumor subpopulation interactions in neoplasms. , 1983, Biochimica et biophysica acta.
[27] S. Levin. Lectu re Notes in Biomathematics , 1983 .
[28] I. Fidler,et al. Development of biological diversity and susceptibility to chemotherapy in murine cancer metastases. , 1984, Cancer research.
[29] P. Nowell. Mechanisms of tumor progression. , 1986, Cancer research.
[30] E. Trucco,et al. Mathematical models for cellular systems. The von foerster equation. Part II , 1965 .
[31] M Gyllenberg,et al. Quiescence as an explanation of Gompertzian tumor growth. , 1989, Growth, development, and aging : GDA.
[32] G. Papa,et al. Modification of the volumetric growth responses and steady-state hypoxic fractions of xenografted DLD-2 human colon carcinomas by administration of basic fibroblast growth factor or suramin. , 1992, British Journal of Cancer.
[33] W. Kendal,et al. Gompertzian growth as a consequence of tumor heterogeneity , 1985 .
[34] B. Fisher,et al. Experimental studies of factors influencing hepatic metastases. II. Effect of partial hepatectomy , 1959, Cancer.
[35] R T Schimke,et al. Gene amplification in cultured cells. , 1988, The Journal of biological chemistry.
[36] S. Michelson. A system for Monte Carlo simulation of heterogeneous tumor cell populations , 1990 .
[37] P. Månsson,et al. Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[38] R T Prehn,et al. The inhibition of tumor growth by tumor mass. , 1991, Cancer research.
[39] R T Schimke,et al. Gene amplification, drug resistance, and cancer. , 1984, Cancer research.
[40] Environmental stress induced by the tumor bed effect leads to subpopulation exclusion within heterogeneous neoplasms: modeling studies. , 1988, Radiation research.
[41] G. Minuk,et al. Effects of partial hepatectomy on hepatic insulinlike growth factor binding protein‐1 expression , 1992, Hepatology.
[42] B. V. Bronk,et al. The stochastic theory of cell proliferation. , 1968, Biophysical journal.
[43] Goldie Jh,et al. Rationale for the use of alternating non-cross-resistant chemotherapy. , 1982 .
[44] B. Fisher,et al. Experimental Studies of Factors Influencing Hepatic Metastases: III. Effect of Surgical Trauma with Special Reference to Liver Injury , 1959, Annals of surgery.
[45] R. Ruggiero,et al. "Concomitant immunity" in murine tumours of non-detectable immunogenicity. , 1985, British Journal of Cancer.
[46] J H Goldie,et al. The genetic origin of drug resistance in neoplasms: implications for systemic therapy. , 1984, Cancer research.
[47] B. Fisher,et al. Experimental Studies of Factors Influencing Hepatic Metastases: IX. The Pituitary Gland , 1961, Annals of surgery.
[48] Goldie Jh,et al. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979 .
[49] J. Mead,et al. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Rockwell. Effect of host age on the transplantation, growth, and radiation response of EMT6 tumors. , 1981, Cancer research.
[51] J. Leith,et al. Effects of differential cell kill on the dynamic composition of heterogeneous tumors , 1990 .
[52] J. Leith,et al. Interlocking triads of growth control in tumors. , 1995, Bulletin of mathematical biology.
[53] S. I. Rubinow,et al. A maturity-time representation for cell populations. , 1968, Biophysical journal.
[54] K. Matsumoto,et al. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. , 1992, Critical reviews in oncogenesis.
[55] Z Bajzer,et al. Analysis of growth of multicellular tumour spheroids by mathematical models , 1994, Cell proliferation.
[56] R. Gatenby,et al. Population ecology issues in tumor growth. , 1991, Cancer research.
[57] R. Ruggiero,et al. Correlation between seric antitumor activity and concomitant resistance in mice bearing nonimmunogenic tumors. , 1990, Cancer research.
[58] I. Győri,et al. Time-dependent subpopulation induction in heterogeneous tumors. , 1988, Bulletin of mathematical biology.
[59] E. Gorelik. Concomitant tumor immunity and the resistance to a second tumor challenge. , 1983, Advances in cancer research.
[60] I. N. Katz,et al. Stochastic processes for solid tumor kinetics I. surface-regulated growth☆ , 1974 .
[61] N. Fausto. Growth factors in liver development, regeneration and carcinogenesis. , 1991, Progress in growth factor research.
[62] G. Webb,et al. A nonlinear structured population model of tumor growth with quiescence , 1990, Journal of mathematical biology.
[63] J. Leith,et al. Dormancy, regression, and recurrence: towards a unifying theory of tumor growth control. , 1994, Journal of theoretical biology.
[64] I. N. Katz,et al. Stochastic processes for solid tumor kinetics II. Diffusion-regulated growth , 1974 .
[65] R. Prehn. Two competing influences that may explain concomitant tumor resistance. , 1993, Cancer research.
[66] J. Leith,et al. Compositional stability of artificial heterogeneous tumors in vivo: use of mitomycin C as a cytotoxic probe. , 1988, Cancer research.
[67] K. Kurokawa,et al. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats , 1993, Hepatology.
[68] G. Poste,et al. Interactions between tumor cell subpopulations in malignant tumors. , 1983, Symposium on Fundamental Cancer Research.
[69] J. Leith,et al. Effects of partial hepatectomy on the growth characteristics and hypoxic fractions of xenografted DLD-2 human colon cancers. , 1992, Radiation research.
[70] Miljenko Marušić,et al. PREDICTION POWER OF MATHEMATICAL MODELS FOR TUMOR GROWTH , 1993 .
[71] C. Cornelisse,et al. A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy. , 1991, British Journal of Cancer.
[72] J. Goldie,et al. A model for the resistance of tumor cells to cancer chemotherapeutic agents , 1983 .
[73] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[74] B. Nordlinger,et al. Dormant liver metastases: an experimental study , 1992, The British journal of surgery.
[75] J. Leith,et al. Autocrine and paracrine growth factors in tumor growth: a mathematical model. , 1991, Bulletin of mathematical biology.
[76] L Kates,et al. Multi‐Type Galton‐Watson Process As A Model For Proliferating Human Tumour Cell Populations Derived From Stem Cells: Estimation of Stem Cell Self‐Renewal Probabilities In Human Ovarian Carcinomas , 1986, Cell and tissue kinetics.
[77] S. Watson,et al. Co-stimulation of gastrointestinal tumour cell growth by gastrin, transforming growth factor alpha and insulin like growth factor-I. , 1991, British Journal of Cancer.